Hypertension and Lipid Management in Prediabetic States
Article first published online: 5 APR 2011
© 2011 Wiley Periodicals, Inc.
The Journal of Clinical Hypertension
Volume 13, Issue 4, pages 270–274, April 2011
How to Cite
Garber, A. J. (2011), Hypertension and Lipid Management in Prediabetic States. The Journal of Clinical Hypertension, 13: 270–274. doi: 10.1111/j.1751-7176.2011.00451.x
- Issue published online: 5 APR 2011
- Article first published online: 5 APR 2011
- Manuscript received November 30, 2010; revised February 4, 2011; accepted February 4, 2011
Patients with prediabetes have impaired fasting glucose, impaired glucose tolerance, and the metabolic syndrome. They have similar coronary heart disease risk rates as patients with type 2 diabetes. Goals and agents for blood pressure and lipid management should be the same for patients with prediabetes as those for patients with overt diabetes. Multiple antihypertensive agents are likely necessary for normotension. Aggressive statin usage is the first-line lipid therapy and concomitant fibrate and nicotinic acid usage should be reserved for failures in primary prevention. J Clin Hypertens (Greenwich). 2011;13:270–274. © 2011 Wiley Periodicals, Inc.